# VASCular Impact of Angiogenic Treatment in Patients With Advanced Colorectal Cancer

> **NCT04813913** · PHASE4 · COMPLETED · sponsor: **University Hospital, Rouen** · enrollment: 13 (actual)

## Conditions studied

- Oncology

## Interventions

- **DRUG:** Bevacizumab in combination with chemotherapy based on fluoropyrimidine IV

## Key facts

- **NCT ID:** NCT04813913
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-05
- **Primary completion:** 2022-07-21
- **Final completion:** 2022-07-21
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04813913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04813913, "VASCular Impact of Angiogenic Treatment in Patients With Advanced Colorectal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04813913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*